Imaging and blood biomarkers to predict graft failure after hsct

Ended Project Grant Awarded Last action

Award ID
R01HL146668
Recipient
Awarding agency
Obligated
$5,178,653

Award facts

Assistance listing
93.837 Cardiovascular Diseases Research
Completion date
Originally
Funding
  • $4,613,379.00 Federal
  • $565,274.00 Non-federal
Place of performance
Georgia, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $581,140 $0
Amendment $569,118 $0
Amendment $569,118 $0
Amendment $565,274 $0
Amendment $565,274 $0
Amendment Imaging and blood biomarkers to predict graft failure after hsct - allogeneic hematopoietic stem cell transplantation (hsct) has allowed patients to be cured… $565,274 $565,274
Amendment $553,550 $0
Amendment $0 $0
Original award $644,631 $0
Show all 15

Subawards

Subrecipient Amount Awarded
Regents Of The University Of Michigan Imaging and Blood Biomarkers to Predict Graft Failure $78,453
Oklahoma University Of $246,721

Quick answers

Who received award R01HL146668?

R01HL146668 was awarded to Emory University by National Heart Lung and Blood Institute (National Institutes of Health) on September 25, 2019.

How much is award R01HL146668 worth?

$5,178,653 has been obligated on R01HL146668: $4,613,379 in federal funding and $565,274 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award